Working with Merck on Keytruda: Advaxis Prostate median survivability 33.7 months https://finance.yahoo.com/news/advaxis-announces-updated-survival-data-130010009.html February conference schedule ASCO IASLC (lung cancer) and Immuno 360 http://ir.advaxis.com/ Corporate presentation: https://advaxis.com/corporate-presentation/
